New analysis reveals highly dynamic and resilient market for new psychoactive substances

The EU market for new psychoactive substances (NPS) is highly dynamic and resilient, characterised by a high turnover of potent, cheap and available substances. This is according to a new study released today by the EMCDDA and Europol: EU Drug Market: New psychoactive substances. The analysis describes the European market for NPS, from production and trafficking, to distribution and use, with a comprehensive overview on synthetic cathinones, cannabinoids, opioids and benzodiazepines. It also details the processes, materials and criminal actors involved at different stages and levels of the…